Cardiac toxicity of checkpoint inhibitors (CPI) used in cancer immunotherapy
Saved in:
| Main Authors: | Alexandru Grigorescu, Mihaela Teodorescu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Medichub Media
2023-01-01
|
| Series: | Oncolog-Hematolog.ro |
| Online Access: | http://www.medichub.ro/reviste-de-specialitate/oncolog-hematolog-ro/cardiac-toxicity-of-checkpoint-inhibitors-cpi-used-in-cancer-immunotherapy-id-7746-cmsid-68 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Association between smoking status, toxicity and survival in the checkpoint inhibitor immunotherapy
by: Anna Rudzińska, et al.
Published: (2024-11-01) -
Real-world and clinical trials for assessing the effectiveness of new drugs in oncology. The role of observational studies with exemplification in non-small cell lung cancer (NSCLC)
by: Mihaela Teodorescu, et al.
Published: (2022-01-01) -
Real-world evidence with nivolumab in advanced non-small cell lung cancer – second line and beyond. Our experience in Romania following straightaway reimbursement of healthcare costs
by: Mihaela Teodorescu, et al.
Published: (2023-01-01) -
Immunotherapeutic Potential of Lactobacillus Species as Immune Checkpoint Inhibitors in Cancer Immunotherapy
by: Renukadevi J, et al.
Published: (2025-01-01) -
Nanomaterials and immune checkpoint inhibitors in cancer immunotherapy: the synergistic innovation prospects
by: Jing Chen, et al.
Published: (2025-06-01)